Biotech · Private company
OBI Pharma, Inc
Track this companyFree. Adds OBI Pharma, Inc to your Dealase workspace and tells you when its record changes.
Clinical trials73 recruiting or active
Pipeline programs10From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline10
- adagloxad simolenin combined with OBI-821Phase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Globo H IHC AssayPhase 3 · Triple Negative Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- CyclophosphamidePhase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
- Globo H IHC AssayPhase 2 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- OBI-3424Phase 2 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OBI-888Phase 2 · Metastatic Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- OBI-902Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OBI-992Phase 2 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OBI-999Phase 2 · Locally Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- OPT-822/OPT-821(30 μg/100 μg)Phase 2 · Metastatic Breast CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials7
- A Study Evaluating OBI-902 in Participants With Advanced Solid TumorsPHASE1_PHASE2 · RECRUITING · started Aug 4, 2025ClinicalTrials.gov NCT07124117 · fetched Nov 12, 2026
- A Phase 1/2 Study of OBI-992 in Subjects With Advanced Solid TumorsPHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jun 12, 2024ClinicalTrials.gov NCT06480240 · fetched Nov 12, 2026
- Phase 1/2 Study of OBI-999 in Patients With Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Nov 25, 2019ClinicalTrials.gov NCT04084366 · fetched Nov 12, 2026
- Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBCPHASE3 · ACTIVE_NOT_RECRUITING · started Dec 5, 2018ClinicalTrials.gov NCT03562637 · fetched Nov 12, 2026
- A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid TumorsPHASE1_PHASE2 · TERMINATED · started Jul 2, 2018ClinicalTrials.gov NCT03592264 · fetched Nov 12, 2026
- This Study is to Evaluate Safe and Effective Treatment Dose of OBI-888 in Patients With Locally Advanced or Metastatic Solid Tumors.PHASE1_PHASE2 · TERMINATED · started May 7, 2018ClinicalTrials.gov NCT03573544 · fetched Nov 12, 2026
- Trial of Active Immunotherapy With Globo H-KLH (OPT-822) in Metastatic Breast Cancer SubjectsPHASE2 · COMPLETED · started Dec 1, 2011ClinicalTrials.gov NCT01516307 · fetched Nov 12, 2026